RANDAL J KIRK Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for RANDAL J KIRK.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of RANDAL J KIRK. RANDAL J KIRK is Director in CLINICAL DATA INC ($NOVI) and 10% Owner in AmpliPhi Biosciences Corp ($APHB) and 10% Owner in Fibrocell Science, Inc. ($FCSC) and 10% Owner in SOLIGENIX, INC. ($DOR) and 10% Owner in Synthetic Biologics, Inc. ($SYN) and 10% Owner in TRANSGENOMIC INC ($TBIO) and Director in ZIOPHARM ONCOLOGY INC ($ZIOP) and 10% Owner in HALOZYME THERAPEUTICS INC ($GYHT) and Director in HALOZYME THERAPEUTICS INC ($GYHT) and 10% Owner in ORAGENICS INC ($OGEN) and 10% Owner in INTREXON CORP ($XON) and Chief Executive Officer in INTREXON CORP ($XON) and Director in INTREXON CORP ($XON) and Executive Chairman in INTREXON CORP ($XON) and 10% Owner in HISTOGENICS CORP ($HSGX) and 10% Owner in AquaBounty Technologies, Inc. ($AQB).

Latest Insider Trading Transactions of RANDAL J KIRK

Sentiment: All, AQB, APHB, NOVI, FCSC, GYHT, HSGX, OGEN, XON, PRPO, SNGX, SYN, ZIOP

Page:   < prev 1 2 3 4 5 6 6 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 21 2019XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyP4.6953,002248,57916,977,97516.9 M to 17 M (+0.31 %)
May 15 2019XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyP4.5962,810288,298846,019783.2 K to 846 K (+8.02 %)
May 15 2019XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyP4.3729,500128,915783,209753.7 K to 783.2 K (+3.91 %)
May 15 2019XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyP4.2575,386320,391753,709678.3 K to 753.7 K (+11.11 %)
May 15 2019XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyP4.59125,620576,596381,605256 K to 381.6 K (+49.07 %)
May 15 2019XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyP4.3759,000257,830255,985197 K to 256 K (+29.95 %)
May 15 2019XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyP4.25150,773640,785196,98546.2 K to 197 K (+326.26 %)
May 15 2019XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyP4.59125,620576,596381,605256 K to 381.6 K (+49.07 %)
May 15 2019XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyP4.3759,000257,830255,985197 K to 256 K (+29.95 %)
May 15 2019XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyP4.25150,773640,785196,98546.2 K to 197 K (+326.26 %)
May 15 2019XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyP4.592,54411,677145,395142.9 K to 145.4 K (+1.78 %)
May 15 2019XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyP4.371,1955,222142,851141.7 K to 142.9 K (+0.84 %)
May 15 2019XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyP4.253,05312,975141,656138.6 K to 141.7 K (+2.20 %)
May 15 2019XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyP4.595,26024,14397,26692 K to 97.3 K (+5.72 %)
May 15 2019XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyP4.372,47110,79892,00689.5 K to 92 K (+2.76 %)
May 15 2019XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyP4.256,31426,83589,53583.2 K to 89.5 K (+7.59 %)
May 15 2019XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyP4.597,05032,360143,318136.3 K to 143.3 K (+5.17 %)
May 15 2019XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyP4.373,31114,469136,268133 K to 136.3 K (+2.49 %)
May 15 2019XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyP4.258,46235,964132,957124.5 K to 133 K (+6.80 %)
May 15 2019XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyP4.5925,611117,5541,044,9021 M to 1 M (+2.51 %)
May 15 2019XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyP4.3712,02952,5671,019,2911 M to 1 M (+1.19 %)
May 15 2019XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyP4.2530,739130,6411,007,262976.5 K to 1 M (+3.15 %)
May 15 2019XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyP4.5958,994270,7821,098,7001 M to 1.1 M (+5.67 %)
May 15 2019XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyP4.3727,708121,0841,039,7061 M to 1 M (+2.74 %)
May 15 2019XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyP4.2570,807300,9301,011,998941.2 K to 1 M (+7.52 %)
May 15 2019XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyP4.597,17632,938171,860164.7 K to 171.9 K (+4.36 %)
May 15 2019XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyP4.373,37014,727164,684161.3 K to 164.7 K (+2.09 %)
May 15 2019XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyP4.258,61336,605161,314152.7 K to 161.3 K (+5.64 %)
May 15 2019XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyP4.5925,234115,824946,910921.7 K to 946.9 K (+2.74 %)
May 15 2019XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyP4.3711,85251,793921,676909.8 K to 921.7 K (+1.30 %)
May 15 2019XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyP4.2530,287128,720909,824879.5 K to 909.8 K (+3.44 %)
May 15 2019XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyP4.5956,733260,404966,043909.3 K to 966 K (+6.24 %)
May 15 2019XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyP4.3726,646116,443909,310882.7 K to 909.3 K (+3.02 %)
May 15 2019XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyP4.2568,093289,395882,664814.6 K to 882.7 K (+8.36 %)
May 15 2019XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyP4.597,47434,306171,702164.2 K to 171.7 K (+4.55 %)
May 15 2019XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyP4.373,51115,343164,228160.7 K to 164.2 K (+2.18 %)
May 15 2019XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyP4.258,97138,127160,717151.7 K to 160.7 K (+5.91 %)
May 15 2019XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyP4.59275,0011,262,25516,924,97316.6 M to 16.9 M (+1.65 %)
May 15 2019XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyP4.37129,158564,42016,649,97216.5 M to 16.6 M (+0.78 %)
May 15 2019XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyP4.25330,0601,402,75516,520,81416.2 M to 16.5 M (+2.04 %)
May 02 2019XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA0.00508,61702,091,1411.6 M to 2.1 M (+32.14 %)
May 02 2019XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA4.5643,887200,12516,190,75416.1 M to 16.2 M (+0.27 %)
Apr 03 2019XONINTREXON CORPKIRK RANDAL J10% OwnerSellS0.6569,16144,955165,332234.5 K to 165.3 K (-29.49 %)
Apr 03 2019XONINTREXON CORPKIRK RANDAL J10% OwnerSellS0.6526,08016,95262,34288.4 K to 62.3 K (-29.49 %)
Apr 03 2019XONINTREXON CORPKIRK RANDAL J10% OwnerSellS0.669,9096,540234,493244.4 K to 234.5 K (-4.05 %)
Apr 03 2019XONINTREXON CORPKIRK RANDAL J10% OwnerSellS0.663,7372,46688,42292.2 K to 88.4 K (-4.05 %)
Apr 03 2019XONINTREXON CORPKIRK RANDAL J10% OwnerSellS0.6730,26520,278244,402274.7 K to 244.4 K (-11.02 %)
Apr 03 2019XONINTREXON CORPKIRK RANDAL J10% OwnerSellS0.6711,4137,64792,159103.6 K to 92.2 K (-11.02 %)
Apr 03 2019SYNSynthetic Biologic ...KIRK RANDAL J10% OwnerSellS0.6569,16144,955165,332234.5 K to 165.3 K (-29.49 %)
Apr 03 2019SYNSynthetic Biologic ...KIRK RANDAL J10% OwnerSellS0.6526,08016,95262,34288.4 K to 62.3 K (-29.49 %)
Apr 03 2019SYNSynthetic Biologic ...KIRK RANDAL J10% OwnerSellS0.669,9096,540234,493244.4 K to 234.5 K (-4.05 %)
Apr 03 2019SYNSynthetic Biologic ...KIRK RANDAL J10% OwnerSellS0.663,7372,46688,42292.2 K to 88.4 K (-4.05 %)
Apr 03 2019SYNSynthetic Biologic ...KIRK RANDAL J10% OwnerSellS0.6730,26520,278244,402274.7 K to 244.4 K (-11.02 %)
Apr 03 2019SYNSynthetic Biologic ...KIRK RANDAL J10% OwnerSellS0.6711,4137,64792,159103.6 K to 92.2 K (-11.02 %)
Feb 04 2019XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA7.6626,109199,99516,083,75116.1 M to 16.1 M (+0.16 %)
Jan 15 2019HSGXHISTOGENICS CORPKIRK RANDAL J10% OwnerSellS0.15345,89751,8851,692,3662 M to 1.7 M (-16.97 %)
Jan 15 2019HSGXHISTOGENICS CORPKIRK RANDAL J10% OwnerSellS0.16400,50764,0812,038,2632.4 M to 2 M (-16.42 %)
Jan 15 2019HSGXHISTOGENICS CORPKIRK RANDAL J10% OwnerSellS0.17251,80042,8062,438,7702.7 M to 2.4 M (-9.36 %)
Jan 15 2019XONINTREXON CORPKIRK RANDAL J10% OwnerSellS0.15345,89751,8851,692,3662 M to 1.7 M (-16.97 %)
Jan 15 2019XONINTREXON CORPKIRK RANDAL J10% OwnerSellS0.16400,50764,0812,038,2632.4 M to 2 M (-16.42 %)
Jan 15 2019XONINTREXON CORPKIRK RANDAL J10% OwnerSellS0.17251,80042,8062,438,7702.7 M to 2.4 M (-9.36 %)
Jan 08 2019XONINTREXON CORPKIRK RANDAL JChief Executive Off ...Option ExerciseA0.0013,775013,775
Jan 08 2019XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA0.0013,774016,057,64216 M to 16.1 M (+0.09 %)
Jan 08 2019XONINTREXON CORPKIRK RANDAL JChief Executive Off ...Option ExerciseA0.0013,775013,775
Jan 08 2019XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA0.0013,774016,057,64216 M to 16.1 M (+0.09 %)
Jan 02 2019XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA6.5430,581200,00016,043,86816 M to 16 M (+0.19 %)
Jan 02 2019XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA8.2996,501799,9931,582,5241.5 M to 1.6 M (+6.49 %)
Dec 03 2018XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA0.0020,408016,013,28716 M to 16 M (+0.13 %)
Dec 03 2018XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA0.0077,59401,486,0231.4 M to 1.5 M (+5.51 %)
Nov 23 2018XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyJ0.007,537083,22175.7 K to 83.2 K (+9.96 %)
Nov 23 2018XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyJ0.0010,3140124,495114.2 K to 124.5 K (+9.03 %)
Nov 23 2018XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyJ0.0046,212046,2120 to 46.2 K
Nov 23 2018XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyJ0.0046,212046,2120 to 46.2 K
Nov 23 2018XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyJ0.0036,0970976,523940.4 K to 976.5 K (+3.84 %)
Nov 23 2018XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyJ0.0090,8360941,191850.4 K to 941.2 K (+10.68 %)
Nov 23 2018XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyJ0.0012,6940152,701140 K to 152.7 K (+9.07 %)
Nov 23 2018XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyJ0.003,5700138,603135 K to 138.6 K (+2.64 %)
Nov 23 2018XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyJ0.0036,4930879,537843 K to 879.5 K (+4.33 %)
Nov 23 2018XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyJ0.0094,0090814,571720.6 K to 814.6 K (+13.05 %)
Nov 23 2018XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyJ0.0012,6940151,746139.1 K to 151.7 K (+9.13 %)
Nov 02 2018XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA11.5617,301200,00015,992,87916 M to 16 M (+0.11 %)
Nov 02 2018XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA14.4255,478799,9931,408,4291.4 M to 1.4 M (+4.10 %)
Oct 29 2018AQBAquaBounty Technol ...KIRK RANDAL J10% OwnerOption ExerciseX2.001,538,4613,076,9220
Oct 29 2018AQBAquaBounty Technol ...KIRK RANDAL J10% OwnerBuyX2.001,538,4613,076,9228,239,1996.7 M to 8.2 M (+22.96 %)
Oct 29 2018XONINTREXON CORPKIRK RANDAL J10% OwnerOption ExerciseX2.001,538,4613,076,9220
Oct 29 2018XONINTREXON CORPKIRK RANDAL J10% OwnerBuyX2.001,538,4613,076,9228,239,1996.7 M to 8.2 M (+22.96 %)
Oct 09 2018XONINTREXON CORPKIRK RANDAL JDirectorOption ExerciseJ0.00130,84900
Oct 09 2018ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorOption ExerciseJ0.00130,84900
Oct 09 2018XONINTREXON CORPKIRK RANDAL JDirectorOption ExerciseJ0.00130,84900
Oct 09 2018ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorOption ExerciseJ0.00130,84900
Oct 01 2018XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA17.2211,614199,99315,975,57816 M to 16 M (+0.07 %)
Oct 01 2018XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA14.3155,904799,9861,352,9511.3 M to 1.4 M (+4.31 %)
Sep 28 2018XONINTREXON CORPKIRK RANDAL JDirectorOption ExerciseJ0.001,2950130,849
Sep 28 2018ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorOption ExerciseJ0.001,2950130,849
Sep 05 2018XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA15.3813,003199,98615,963,96416 M to 16 M (+0.08 %)
Sep 05 2018XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA13.7458,224799,9981,297,0471.2 M to 1.3 M (+4.70 %)
Aug 31 2018XONINTREXON CORPKIRK RANDAL JDirectorOption ExerciseJ0.001,2820129,554
Aug 31 2018ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorOption ExerciseJ0.001,2820129,554
Aug 30 2018TBIOPrecipio, Inc.KIRK RANDAL J10% OwnerSellS0.4150020527,15127.7 K to 27.2 K (-1.81 %)
Aug 30 2018TBIOPrecipio, Inc.KIRK RANDAL J10% OwnerSellS0.414,9202,017266,904271.8 K to 266.9 K (-1.81 %)
Aug 30 2018TBIOPrecipio, Inc.KIRK RANDAL J10% OwnerSellS0.419,3403,829506,657516 K to 506.7 K (-1.81 %)
Aug 30 2018TBIOPrecipio, Inc.KIRK RANDAL J10% OwnerSellS0.419,8404,034533,809543.6 K to 533.8 K (-1.81 %)
Aug 28 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS18.02256,8604,628,6171,897,6102.2 M to 1.9 M (-11.92 %)
Aug 28 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS18.2264,9961,184,2272,154,4702.2 M to 2.2 M (-2.93 %)
Aug 28 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS18.2061,4281,117,9902,219,4662.3 M to 2.2 M (-2.69 %)
Aug 28 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS18.02175,3893,160,5103,900,9194.1 M to 3.9 M (-4.30 %)
Aug 28 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS18.2244,381808,6224,076,3084.1 M to 4.1 M (-1.08 %)
Aug 28 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS18.2041,944763,3814,120,6894.2 M to 4.1 M (-1.01 %)
Aug 23 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS18.48149,3532,760,0432,280,8942.4 M to 2.3 M (-6.15 %)
Aug 23 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.49464,6248,126,2742,430,2472.9 M to 2.4 M (-16.05 %)
Aug 23 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.1595,8191,643,2962,894,8713 M to 2.9 M (-3.20 %)
Aug 23 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS18.48101,9821,884,6274,162,6334.3 M to 4.2 M (-2.39 %)
Aug 23 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.49317,2575,548,8254,264,6154.6 M to 4.3 M (-6.92 %)
Aug 23 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.1565,4271,122,0734,581,8724.6 M to 4.6 M (-1.41 %)
Aug 16 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.2456,668976,9562,985,0543 M to 3 M (-1.86 %)
Aug 16 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.1554,397932,9093,041,7223.1 M to 3 M (-1.76 %)
Aug 16 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.36180,1543,127,4733,096,1193.3 M to 3.1 M (-5.50 %)
Aug 16 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.2438,695667,1024,643,4514.7 M to 4.6 M (-0.83 %)
Aug 16 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.1537,144637,0204,682,1464.7 M to 4.7 M (-0.79 %)
Aug 16 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.36123,0142,135,5234,719,2904.8 M to 4.7 M (-2.54 %)
Aug 10 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.08120,6062,059,9503,276,2733.4 M to 3.3 M (-3.55 %)
Aug 10 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.48132,5912,317,6913,396,8793.5 M to 3.4 M (-3.76 %)
Aug 10 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.5287,1851,527,4813,529,4703.6 M to 3.5 M (-2.41 %)
Aug 10 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.0882,3531,406,5894,842,3044.9 M to 4.8 M (-1.67 %)
Aug 10 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.4890,5361,582,5694,924,6575 M to 4.9 M (-1.81 %)
Aug 10 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.5259,5331,043,0185,015,1935.1 M to 5 M (-1.17 %)
Aug 01 2018XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA14.6613,642199,99215,950,96115.9 M to 16 M (+0.09 %)
Aug 01 2018XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA15.3852,015799,9911,238,8231.2 M to 1.2 M (+4.38 %)
Jul 31 2018XONINTREXON CORPKIRK RANDAL JDirectorOption ExerciseJ0.001,2700128,272
Jul 31 2018ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorOption ExerciseJ0.001,2700128,272
Jul 27 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS16.9029,074491,3513,616,6553.6 M to 3.6 M (-0.80 %)
Jul 27 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.3089,1361,542,0533,645,7293.7 M to 3.6 M (-2.39 %)
Jul 27 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.3261,7411,069,3543,734,8653.8 M to 3.7 M (-1.63 %)
Jul 27 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS16.9019,853335,5165,074,7265.1 M to 5.1 M (-0.39 %)
Jul 27 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.3060,8641,052,9475,094,5795.2 M to 5.1 M (-1.18 %)
Jul 27 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.3242,159730,1945,155,4435.2 M to 5.2 M (-0.81 %)
Jul 06 2018XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyP13.371,121,91414,999,99015,937,31914.8 M to 15.9 M (+7.57 %)
Jul 06 2018XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyP13.376,357,51785,000,00214,140,1397.8 M to 14.1 M (+81.69 %)
Jul 02 2018XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA13.9414,347199,99714,815,40514.8 M to 14.8 M (+0.10 %)
Jul 02 2018XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA16.1549,535799,9901,186,8081.1 M to 1.2 M (+4.36 %)
Jun 29 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS16.9772,7531,234,6183,796,6063.9 M to 3.8 M (-1.88 %)
Jun 29 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS16.9772,7531,234,6183,796,6063.9 M to 3.8 M (-1.88 %)
Jun 29 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS16.9976,2911,296,1843,869,3593.9 M to 3.9 M (-1.93 %)
Jun 29 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS16.9976,2911,296,1843,869,3593.9 M to 3.9 M (-1.93 %)
Jun 29 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.3431,795551,3253,945,6504 M to 3.9 M (-0.80 %)
Jun 29 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS17.3431,795551,3253,945,6504 M to 3.9 M (-0.80 %)
Jun 29 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS16.9749,678843,0365,197,6025.2 M to 5.2 M (-0.95 %)
Jun 29 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS16.9749,678843,0365,197,6025.2 M to 5.2 M (-0.95 %)
Jun 29 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS16.9952,094885,0775,247,2805.3 M to 5.2 M (-0.98 %)
Jun 29 2018GYHTHALOZYME THERAPEUT ...KIRK RANDAL J10% OwnerSellS16.9952,094885,0775,247,2805.3 M to 5.2 M (-0.98 %)

Page:   < prev 1 2 3 4 5 6 6 next >